STOCK TITAN

NOVO INTEGRATED SCIENCES (NVOS) Stock Price, News & Analysis

NVOS OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
94 176 sessions, October 27, 2025 to October 28, 2026
Largest daily move
+900% close of November 25, 2025
1-year change
-88% closing prices, October 27, 2025 to October 28, 2026
1-month change
-84.6% closing prices, September 28, 2026 to October 28, 2026

Company Description

NOVO INTEGRATED SCIENCES (OTC: NVOS) is classified in the medical care facilities industry within the Healthcare sector and carries a market capitalization of $76.9K.

NVOS has declined 88.0% over the past year. The last closing price was $0.0006.

For FY2024, NOVO INTEGRATED SCIENCES reported revenue of $13.3M with net income of -$16.2M and diluted earnings per share of -$0.89.

This page collects what Stock Titan holds for NVOS, including price data, latest news, financial highlights, and short interest trends.

Stock Performance

$0.0039
+550.00%
+0.00
Last updated: October 29, 2026 at 11:07
-88%
Performance 1 year
$76.9K

NOVO INTEGRATED SCIENCES (NVOS) closed at $0.0006 on October 28, 2026. Over the past 12 months, the price has lost 88.0%.

See what a $1,000 investment in NVOS would be worth today

Average down calculator for NVOS

NVOS Metrics & Rankings

Price returns through October 28, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

NOVO INTEGRATED SCIENCES has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, buybacks, conferences. View all NVOS news →

SEC Filings

No SEC filings available for NVOS.

Financial Highlights

NOVO INTEGRATED SCIENCES generated $13.3M in revenue in FY2024, retaining a 43.2% gross margin, operating income reached -$10.1M (-75.8% operating margin), and net income was -$16.2M. Diluted earnings per share stood at -$0.89. The company generated -$5.1M in operating cash flow. The current ratio was 0.37, measuring current assets divided by current liabilities.

$13.3M
Revenue (FY2024)
-$16.2M
Net Income (FY2024)
-$5.1M
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in NOVO INTEGRATED SCIENCES (NVOS) currently stands at 92 shares, representing 0.0% of the float.

Days to Cover History

Last 12 Months

Days to cover for NOVO INTEGRATED SCIENCES (NVOS) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

NVOS Company Profile & Sector Positioning

NOVO INTEGRATED SCIENCES (NVOS) operates in the Medical Care Facilities industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing NVOS often look at related companies in the same sector, including CLEARDAY INC (CLRD), IMAC HOLDINGS INC (BACK), ASSURE HLDGS CORP (IONM), GENESIS HEALTHCARE INC A (GENN), and NUMINUS WELLNESS INC (NUMIF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NVOS's relative position within its industry.

Frequently Asked Questions

What is the current stock price of NOVO INTEGRATED SCIENCES (NVOS)?

The current stock price of NOVO INTEGRATED SCIENCES (NVOS) is $0.0039 as of October 29, 2026.

What is the market cap of NOVO INTEGRATED SCIENCES (NVOS)?

The market cap of NOVO INTEGRATED SCIENCES (NVOS) is approximately $76.9K. Learn more about what market capitalization means .

What is the revenue of NOVO INTEGRATED SCIENCES (NVOS) stock?

The FY2024 revenue of NOVO INTEGRATED SCIENCES (NVOS) is $13.3M, from its most recent completed fiscal year.

What is the net income of NOVO INTEGRATED SCIENCES (NVOS)?

The FY2024 net income of NOVO INTEGRATED SCIENCES (NVOS) is -$16.2M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of NOVO INTEGRATED SCIENCES (NVOS)?

The diluted earnings per share (EPS) of NOVO INTEGRATED SCIENCES (NVOS) is -$0.89 for FY2024, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of NOVO INTEGRATED SCIENCES (NVOS)?

The operating cash flow of NOVO INTEGRATED SCIENCES (NVOS) is -$5.1M for FY2024, its most recent completed fiscal year. Learn about cash flow.

What is the operating margin of NOVO INTEGRATED SCIENCES (NVOS)?

The operating profit margin of NOVO INTEGRATED SCIENCES (NVOS) is -75.8% for FY2024, its most recent completed fiscal year. Learn about operating margins.

What is the gross margin of NOVO INTEGRATED SCIENCES (NVOS)?

The gross profit margin of NOVO INTEGRATED SCIENCES (NVOS) is 43.2% for FY2024, its most recent completed fiscal year. Learn about gross margins.

What is the current ratio of NOVO INTEGRATED SCIENCES (NVOS)?

The current ratio of NOVO INTEGRATED SCIENCES (NVOS), current assets divided by current liabilities, was 0.37 at the end of FY2024, its most recent completed fiscal year. Learn about liquidity ratios.

What is the gross profit of NOVO INTEGRATED SCIENCES (NVOS)?

The gross profit of NOVO INTEGRATED SCIENCES (NVOS) is $5.7M for FY2024, its most recent completed fiscal year.

What is the operating income of NOVO INTEGRATED SCIENCES (NVOS)?

The operating income of NOVO INTEGRATED SCIENCES (NVOS) is -$10.1M for FY2024, its most recent completed fiscal year. Learn about operating income.